BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 3142917)

  • 1. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
    Sheckter CB; McLachlan RI; Tenover JS; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1221-4. PubMed ID: 3142917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after shortterm physiologic GnRH replacement--a clinical research center study.
    Seminara SB; Boepple PA; Nachtigall LB; Pralong FP; Khoury RH; Sluss PM; Lecain AE; Crowley WF
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3692-6. PubMed ID: 8855824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications.
    McLachlan RI; Finkel DM; Bremner WJ; Snyder PJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1414-9. PubMed ID: 2110576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive follicle-stimulating hormone responses to intravenous gonadotropin-releasing hormone in boys with idiopathic hypogonadotropic hypogonadism.
    Padmanabhan V; Kelch RP; Sonstein J; Foster CM; Beitins IZ
    J Clin Endocrinol Metab; 1988 Oct; 67(4):793-800. PubMed ID: 3138278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
    Finkelstein JS; Spratt DI; O'Dea LS; Whitcomb RW; Klibanski A; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment--a clinical research center study.
    Nachtigall LB; Boepple PA; Seminara SB; Khoury RH; Sluss PM; Lecain AE; Crowley WF
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3520-5. PubMed ID: 8855795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.
    Bagatell CJ; McLachlan RI; de Kretser DM; Burger HG; Vale WW; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective regulation of glycoprotein free alpha-subunit in males with isolated gonadotropin-releasing hormone deficiency--a clinical research center study.
    Pralong FP; Pavlou SN; Waldstreicher J; Crowley WF; Boepple PA
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3682-8. PubMed ID: 8530620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary.
    Sheckter CB; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):397-401. PubMed ID: 2493030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man.
    Gross KM; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1987 Apr; 64(4):675-80. PubMed ID: 3102545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Hayes FJ; Dwyer A; Boepple PA; Lee H; Crowley WF
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4128-36. PubMed ID: 12213860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism.
    Lavoie HB; Martin KA; Taylor E; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 1998 Jan; 83(1):241-7. PubMed ID: 9435449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic hypogonadotropic hypogonadism in men: dependence of the hormone responses to gonadotropin-releasing hormone (GnRH) on the magnitude of the endogenous GnRH secretory defect.
    Barkan AL; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1118-25. PubMed ID: 3932448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary glycoprotein hormone alpha-subunit secretion after thyrotropin-releasing hormone stimulation in normal men and men with idiopathic hypogonadotropic hypogonadism.
    Winters SJ; Troen P
    J Clin Endocrinol Metab; 1990 Feb; 70(2):544-7. PubMed ID: 1688869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
    Partsch CJ; Hermanussen M; Sippell WG
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.